Two-year Research Study Investigating How Well Semaglutide Works in People Suffering From Overweight or Obesity

NCT03693430 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

304

Enrollment

INDUSTRY

Sponsor class

Conditions

Overweight
Obesity

Interventions

DRUG: Semaglutide
DRUG: Placebo (Semaglutide)

Sponsor

Novo Nordisk A/S